Story · Medicine & Biotech

Cancer Vaccines — From Treatment to Prevention

4 outlets · first reported by NEJM 1d ago · latest 1h ago · 39 hours of coverage · 2 countries

Coverage, in order

  1. 1d ago
    first NEJM indie study peer-reviewed
    Cancer Vaccines — From Treatment to Prevention

    New England Journal of Medicine, Ahead of Print.

  2. 1d ago
    EMJ Reviews UK obscure podcast
    Onc Now: Cancer Vaccines and Agentic AI

    Onc Now: Cancer Vaccines and Agentic AI

  3. 6h ago
    OncoDaily obscure study peer-reviewed
    Mark Yarchoan Discusses Personalized Cancer Vaccines in Melanoma Treatment and Prevention

    Mark Yarchoan, Co-Founder and CSO at Adventris Pharmaceuticals, shared on X: “Excited to share my editorial in the NEJM accompanying the P3 trial of a personalized cancer vaccine in melanoma.

  4. 1h ago
    Medical Xpress indie randomized trial
    Cancer vaccines show promise for treatment and prevention

    For more than three decades, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center researchers have pursued an ambitious idea: that vaccines could train the immune system to recognize and fight cancer. Now, a landmark phase 3 clinical trial of a personalized melanoma vaccine shows that this…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.